SCHEMBL1960303

SCHEMBL1960303

COc1ccc(C(C#N)=Cc2ccc(N3CCC(OP(=O)(OCC(Cl)(Cl)Cl)OCC(Cl)(Cl)Cl)CC3)s2)cc1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.66
▸ ABCG2 Q9UNQ0 1/20 0.66
▸ PDE4B Q07343 5/20 0.38
▸ MEN1 O00255 3/20 0.32
▸ KMT2A Q03164 3/20 0.32
▸ MAPT P10636 2/20 0.32
▸ LMNA P02545 2/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ PTPN7 P35236 1/20 0.31
▸ PTPN12 Q05209 1/20 0.31
▸ PTPN22 Q9Y2R2 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ TUBB4A P04350 1/20 0.31
▸ TUBB P07437 1/20 0.31
▸ TUBA3C P0DPH7 1/20 0.31
▸ TUBA1B P68363 1/20 0.31
▸ TUBA4A P68366 1/20 0.31
▸ TUBB4B P68371 1/20 0.31
▸ TUBB3 Q13509 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1960302 1.00 ABCB1 (0.66) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1957569 0.88 ABCB1 (0.75) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1957568 0.88 ABCB1 (0.75) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1959533 0.88 ABCB1 (0.73) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1959532 0.87 ABCB1 (0.75) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1959534 0.87 ABCB1 (0.75) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1958724 0.83 ABCB1 (0.44) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1958723 0.83 ABCB1 (0.44) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL13172918 0.80 ABCB1 (0.72) ABCB1ABCG2PDE4BMEN1KMT2A
SCHEMBL1960865 0.80 ABCB1 (1.00) ABCB1ABCG2PDE4BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332905-B1 BCRP/ABCG2 Inhibitor YAKULT HONSHA KK (JP) 2017-03-01 — — EP disclosed
US-8697742-B2 BCRP/ABCG2 inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-04-15 — — US disclosed
EP-2332905-A1 BCRP/ABCG3 Inhibitor Kabushiki Kaisha Yakult Honsha (JP) 2011-06-15 — — EP disclosed
US-20090253656-A1 BCRP/ABCG2 INHIBITOR KABUSHIKI KAISHA YAKULT HONSHA (JP) 2009-10-08 — — US disclosed
EP-1864972-A1 BCRP/ABCG2 INHIBITOR Kabushiki Kaisha Yakult Honsha (JP) 2007-12-12 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253656-A1 BCRP/ABCG2 INHIBITOR ABCC1, ABCB1, BRCA1 ABCB1 2/4885ABCG2 7/4885PDE4B 4786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback